Logo image of CREV

CARBON REVOLUTION PLC (CREV) Stock Fundamental Analysis

NASDAQ:CREV - Nasdaq - IE000OD0CSK4 - Common Stock - Currency: USD

3.18  +0.01 (+0.32%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CREV. CREV was compared to 81 industry peers in the Automobile Components industry. CREV has a bad profitability rating. Also its financial health evaluation is rather negative. CREV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year CREV has reported negative net income.
CREV had a negative operating cash flow in the past year.
CREV Yearly Net Income VS EBIT VS OCF VS FCFCREV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M 4M 6M

1.2 Ratios

CREV has a Return On Assets of -3.65%. This is amonst the worse of the industry: CREV underperforms 83.95% of its industry peers.
CREV has a Return On Equity of -4.38%. This is in the lower half of the industry: CREV underperforms 75.31% of its industry peers.
Industry RankSector Rank
ROA -3.65%
ROE -4.38%
ROIC N/A
ROA(3y)2.89%
ROA(5y)N/A
ROE(3y)3.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CREV Yearly ROA, ROE, ROICCREV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 1 -1 2 3

1.3 Margins

CREV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CREV Yearly Profit, Operating, Gross MarginsCREV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

2

2. Health

2.1 Basic Checks

The number of shares outstanding for CREV remains at a similar level compared to 1 year ago.
CREV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CREV Yearly Shares OutstandingCREV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
CREV Yearly Total Debt VS Total AssetsCREV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

CREV has an Altman-Z score of -0.24. This is a bad value and indicates that CREV is not financially healthy and even has some risk of bankruptcy.
CREV has a Altman-Z score of -0.24. This is amonst the worse of the industry: CREV underperforms 91.36% of its industry peers.
CREV has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
CREV has a Debt to Equity ratio of 0.02. This is amongst the best in the industry. CREV outperforms 91.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -0.24
ROIC/WACCN/A
WACCN/A
CREV Yearly LT Debt VS Equity VS FCFCREV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

CREV has a Current Ratio of 0.01. This is a bad value and indicates that CREV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CREV (0.01) is worse than 98.77% of its industry peers.
CREV has a Quick Ratio of 0.01. This is a bad value and indicates that CREV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.01, CREV is not doing good in the industry: 97.53% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
CREV Yearly Current Assets VS Current LiabilitesCREV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M

0

3. Growth

3.1 Past

CREV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -368.49%.
EPS 1Y (TTM)-368.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3282.35%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -611.74% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-15225.22%
EPS Next 2Y-611.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CREV Yearly Revenue VS EstimatesCREV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 20M 40M 60M 80M 100M
CREV Yearly EPS VS EstimatesCREV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 -5 -10 -15 -20

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CREV. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CREV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CREV Price Earnings VS Forward Price EarningsCREV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CREV Per share dataCREV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

CREV's earnings are expected to decrease with -611.74% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-611.74%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CREV!.
Industry RankSector Rank
Dividend Yield N/A

CARBON REVOLUTION PLC

NASDAQ:CREV (5/29/2025, 9:41:54 AM)

3.18

+0.01 (+0.32%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.58%
Inst Owner ChangeN/A
Ins Owners9.57%
Ins Owner ChangeN/A
Market Cap6.01M
Analysts82.86
Price Target39.78 (1150.94%)
Short Float %0.55%
Short Ratio0.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.17
P/tB 0.17
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)-4.84
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.38
OCFYN/A
SpS0
BVpS19.07
TBVpS19.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.65%
ROE -4.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)2.89%
ROA(5y)N/A
ROE(3y)3.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -0.24
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-368.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3282.35%
EPS Next Y-15225.22%
EPS Next 2Y-611.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-24.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-731.34%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-53.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.84%
OCF growth 3YN/A
OCF growth 5YN/A